CH3 BioSystems, LLC Email Format
Biotechnology ResearchNew York, United States2-10 Employees
CH3 BioSystems, LLC operates in the biotechnology research arena, building intellectual property and research tools derived from chemical biology and epigenetics. Its products are intended to aid scientists—biologists, chemists, and clinicians—in developing diagnostics and potential therapies for human and animal diseases by enabling faster, safer, and more efficient research. The company holds patents and IP-protected offerings, including an antibody and related tools that help researchers assess protein methylation status in diseases such as cancer, HIV, and neurodevelopmental, autoimmune, or cardiovascular disorders. CH3 BioSystems is based in Buffalo, New York, and functions as a small enterprise with a focused team. Its stated aim is to advance the field of protein methylation biology while delivering clinically relevant pharmaceutical products for the 21st century.